Daniel Bridges
Impact in
- Pharmacology top 2%
- Cannabis and Cannabinoid Research
- Pharmaceutical industry and healthcare
-
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
Papers in
-
- Neuroscience and Neuropharmacology Research 5
- Neurotransmitter Receptor Influence on Behavior 2
-
- Cannabis and Cannabinoid Research 5
- Pharmaceutical industry and healthcare 3
- Co-authors
- Andrew S.C. Rice (4 shared papers)Steve Thompson (1 shared paper)Leslie Citrome (2 shared papers)Michaela Egertová (1 shared paper)Maurice R. Elphick (1 shared paper)John M. Winter (1 shared paper)Wendy Petry Battisti (2 shared papers)Yvonne E. Yarker (2 shared papers)
- Journals
- Annals of Internal Medicine (2 papers)Neuroscience (1 paper)Chemistry and Physics of Lipids (1 paper)European Journal of Pharmacology (1 paper)Progress in brain research (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Daniel Bridges
10 papers receiving 1.3k citations
Daniel Bridges's Hit Papers
Peers
Comparison fields: 5 of 103
- Pharmacology 513
- Cellular and Molecular Neuroscience 377
- Physiology 472
- Pharmacology 142
- Toxicology 53
Countries citing papers authored by Daniel Bridges
This map shows the geographic impact of Daniel Bridges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Bridges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Bridges more than expected).
Fields of papers citing papers by Daniel Bridges
This network shows the impact of papers produced by Daniel Bridges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Bridges. The network helps show where Daniel Bridges may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Bridges, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 339 | |
| 2 | 2015 | 252 | |
| 3 | 2001 | 195 | |
| 4 | Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update Hit paper breakdown → | 2022 | 165 |
| 5 | 2003 | 149 | |
| 6 | 2009 | 89 | |
| 7 | 2005 | 88 | |
| 8 | 2002 | 76 | |
| 9 | 1998 | 39 | |
| 10 | 2002 | 37 |
About Daniel Bridges
Daniel Bridges is a scholar working on Cellular and Molecular Neuroscience, Pharmacology, Pharmacology, Physiology and Information Systems and Management, having authored 10 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (5 papers), Neuroscience and Neuropharmacology Research (5 papers), Pain Mechanisms and Treatments (3 papers), Pharmaceutical industry and healthcare (3 papers), Neurotransmitter Receptor Influence on Behavior (2 papers), Academic Publishing and Open Access (2 papers), Health and Medical Research Impacts (2 papers) and Nitric Oxide and Endothelin Effects (1 paper). The work is most often cited by research in Pharmacology (513 citations), Cellular and Molecular Neuroscience (377 citations), Physiology (472 citations), Pharmacology (142 citations) and Toxicology (53 citations). Daniel Bridges has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Andrew S.C. Rice, Steve Thompson, Leslie Citrome, Michaela Egertová, Maurice R. Elphick, John M. Winter, Wendy Petry Battisti, Yvonne E. Yarker, Angela Cairns and Karen L. Woolley. Their work appears in journals such as Annals of Internal Medicine, Neuroscience, Chemistry and Physics of Lipids, European Journal of Pharmacology and Progress in brain research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.